Optimization of von Willebrand factor multimer analysis in vertical mini-gel electrophoresis systems: A rapid procedure
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | THOMAZINI, Camila Martos | |
dc.contributor.author | SOARES, Rosangela de Paula Silva | |
dc.contributor.author | ROCHA, Tania Rubia Flores da | |
dc.contributor.author | SACHETTO, Ana Teresa Azevedo | |
dc.contributor.author | SANTORO, Marcelo Larami | |
dc.date.accessioned | 2019-03-26T14:42:25Z | |
dc.date.available | 2019-03-26T14:42:25Z | |
dc.date.issued | 2019 | |
dc.description.abstract | Von Willebrand disease (VWD) is a common cause of bleeding worldwide. Analysis of von Willebrand factor (VWF) multimer distribution (VWF:MD) is essential to properly classify and treat different types of VWD, and it is performed using a SDS agarose gel electrophoresis followed by Western blotting, a handmade technique that demands days to be completed and requires skillful execution. Aiming both to facilitate gel production and to shorten the preparation time, we developed an uncomplicated technique to provide agility in the analysis of VWF:MD, so that it can be easily accomplished in the routine practice of hemostasis laboratories. On that account, we used a commercial vertical mini-gel electrophoresis system for SDS-PAGE and a semi-dry transfer system, which allowed us to analyze VWF:MD of various samples in a period shorter than 12 h. This technique differentiated VWF:MD in human and animal plasmas under normal, congenital and acquired (experimental envenomation by Bothrops jararaca snake) conditions. This optimized method is cheap, rapid, reproducible, easy to be performed, and uses electrophoresis and Western blotting systems available in most laboratories. All these advantages encourage hemostasis professionals to use it in their routine practices. In order to facilitate the setup and accomplishment of the whole procedure step by step, videos were appended to the article. | eng |
dc.description.index | MEDLINE | eng |
dc.description.sponsorship | Sao Paulo Research Foundation (FAPESP) [2013/25177-0, 2013/20239-8] | |
dc.description.sponsorship | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [305245/2015-5] | |
dc.description.sponsorship | Fundacao Butantan | |
dc.identifier.citation | THROMBOSIS RESEARCH, v.175, p.76-83, 2019 | |
dc.identifier.doi | 10.1016/j.thromres.2019.01.018 | |
dc.identifier.issn | 0049-3848 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/31256 | |
dc.language.iso | eng | |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | eng |
dc.relation.ispartof | Thrombosis Research | |
dc.rights | restrictedAccess | eng |
dc.rights.holder | Copyright PERGAMON-ELSEVIER SCIENCE LTD | eng |
dc.subject | ADAMTS13 | eng |
dc.subject | Bleeding | eng |
dc.subject | Diagnosis | eng |
dc.subject | Electrophoresis | eng |
dc.subject | Proteolysis | eng |
dc.subject.other | vonwillebrand-factor | eng |
dc.subject.other | venom metalloproteinases | eng |
dc.subject.other | triplet structure | eng |
dc.subject.other | disulfide bonds | eng |
dc.subject.other | glycoprotein-ib | eng |
dc.subject.other | disease | eng |
dc.subject.other | plasma | eng |
dc.subject.other | classification | eng |
dc.subject.other | diagnosis | eng |
dc.subject.other | thrombocytopenia | eng |
dc.subject.wos | Hematology | eng |
dc.subject.wos | Peripheral Vascular Disease | eng |
dc.title | Optimization of von Willebrand factor multimer analysis in vertical mini-gel electrophoresis systems: A rapid procedure | eng |
dc.type | article | eng |
dc.type.category | original article | eng |
dc.type.version | publishedVersion | eng |
dspace.entity.type | Publication | |
hcfmusp.citation.scopus | 8 | |
hcfmusp.contributor.author-fmusphc | CAMILA MARTOS THOMAZINI | |
hcfmusp.contributor.author-fmusphc | ROSANGELA DE PAULA SILVA SOARES | |
hcfmusp.contributor.author-fmusphc | TANIA RUBIA FLORES DA ROCHA | |
hcfmusp.contributor.author-fmusphc | ANA TERESA AZEVEDO SACHETTO | |
hcfmusp.contributor.author-fmusphc | MARCELO LARAMI SANTORO | |
hcfmusp.description.beginpage | 76 | |
hcfmusp.description.endpage | 83 | |
hcfmusp.description.volume | 175 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 30731387 | |
hcfmusp.origem.scopus | 2-s2.0-85060920911 | |
hcfmusp.origem.wos | WOS:000458802600014 | |
hcfmusp.publisher.city | OXFORD | eng |
hcfmusp.publisher.country | ENGLAND | eng |
hcfmusp.relation.reference | Bowen DJ, 2007, THROMB HAEMOSTASIS, V97, P1051, DOI 10.1160/TH06-12-0726 | eng |
hcfmusp.relation.reference | Budde U, 2002, SEMIN THROMB HEMOST, V28, P173, DOI 10.1055/s-2002-27820 | eng |
hcfmusp.relation.reference | Budde U, 2015, EXPERT REV HEMATOL, V8, P799, DOI 10.1586/17474086.2015.1060854 | eng |
hcfmusp.relation.reference | Castaman G, 2016, SEMIN THROMB HEMOST, V42, P478, DOI 10.1055/s-0036-1579638 | eng |
hcfmusp.relation.reference | COUNTS RB, 1978, J CLIN INVEST, V62, P702, DOI 10.1172/JCI109178 | eng |
hcfmusp.relation.reference | DALTON RG, 1988, THROMB RES, V50, P345, DOI 10.1016/0049-3848(88)90237-X | eng |
hcfmusp.relation.reference | DONG ZG, 1994, J BIOL CHEM, V269, P6753 | eng |
hcfmusp.relation.reference | Favaloro EJ, 2017, HAEMOPHILIA, V23, pE373, DOI 10.1111/hae.13261 | eng |
hcfmusp.relation.reference | Favaloro EJ, 2016, PATHOLOGY, V48, P303, DOI 10.1016/j.pathol.2016.03.001 | eng |
hcfmusp.relation.reference | Favaloro EJ, 2011, BLOOD COAGUL FIBRIN, V22, P553, DOI 10.1097/MBC.0b013e32834a7e01 | eng |
hcfmusp.relation.reference | FEDERICI AB, 1989, BRIT J HAEMATOL, V73, P93, DOI 10.1111/j.1365-2141.1989.tb00226.x | eng |
hcfmusp.relation.reference | Federici AB, 2009, BLOOD, V113, P526, DOI 10.1182/blood-2008-04-152280 | eng |
hcfmusp.relation.reference | Fischer BE, 1998, BIOCHEM J, V331, P483, DOI 10.1042/bj3310483 | eng |
hcfmusp.relation.reference | FOWLER WE, 1985, J CLIN INVEST, V76, P1491, DOI 10.1172/JCI112129 | eng |
hcfmusp.relation.reference | FRETTO LJ, 1986, J BIOL CHEM, V261, P5679 | eng |
hcfmusp.relation.reference | Gorr TA, 2015, PROTEOM CLIN APPL, V9, P396, DOI 10.1002/prca.201400118 | eng |
hcfmusp.relation.reference | GRALNICK HR, 1987, AM J HEMATOL, V24, P259, DOI 10.1002/ajh.2830240305 | eng |
hcfmusp.relation.reference | Haberichter SL, 2008, BLOOD, V111, P4979, DOI 10.1182/blood-2007-09-110940 | eng |
hcfmusp.relation.reference | Haberichter SL, 2006, BLOOD, V108, P3344, DOI 10.1182/blood-2006-04-015065 | eng |
hcfmusp.relation.reference | Harlow E, 1988, ANTIBODIES LAB MANUA, P726 | eng |
hcfmusp.relation.reference | HOYER LW, 1980, BLOOD, V55, P1056 | eng |
hcfmusp.relation.reference | Johnstone IB, 1997, J VET DIAGN INVEST, V9, P314, DOI 10.1177/104063879700900316 | eng |
hcfmusp.relation.reference | Just S, 2017, SEMIN THROMB HEMOST, V43, P75, DOI 10.1055/s-0036-1592164 | eng |
hcfmusp.relation.reference | KAMIGUTI AS, 1991, TOXICON, V29, P961, DOI 10.1016/0041-0101(91)90079-7 | eng |
hcfmusp.relation.reference | Kurien BT, 2003, J IMMUNOL METHODS, V274, P1, DOI 10.1016/S0022-1759(02)00523-9 | eng |
hcfmusp.relation.reference | Laffan M., 2011, DACIE LEWIS PRACTICA, P393 | eng |
hcfmusp.relation.reference | Lenting PJ, 2015, BLOOD, V125, P2019, DOI 10.1182/blood-2014-06-528406 | eng |
hcfmusp.relation.reference | Lopes AA, 2002, BRAZ J MED BIOL RES, V35, P1259, DOI 10.1590/S0100-879X2002001100002 | eng |
hcfmusp.relation.reference | MARUYAMA M, 1990, THROMB HAEMOSTASIS, V63, P449 | eng |
hcfmusp.relation.reference | MILLER JL, 1991, P NATL ACAD SCI USA, V88, P4761, DOI 10.1073/pnas.88.11.4761 | eng |
hcfmusp.relation.reference | Ng C, 2015, BLOOD, V125, P2029, DOI 10.1182/blood-2014-08-528398 | eng |
hcfmusp.relation.reference | Nichols T. C., 2010, THROMBOSIS, V2010 | eng |
hcfmusp.relation.reference | Ott HW, 2010, AM J CLIN PATHOL, V133, P322, DOI 10.1309/AJCPZSBTD2BWOMVL | eng |
hcfmusp.relation.reference | Pasotti F, 2013, ELECTROPHORESIS, V34, P818, DOI 10.1002/elps.201200538 | eng |
hcfmusp.relation.reference | Patton WF, 2000, ELECTROPHORESIS, V21, P1123, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1123::AID-ELPS1123>3.3.CO;2-5 | eng |
hcfmusp.relation.reference | Perutelli P, 1997, HAEMATOLOGICA, V82, P510 | eng |
hcfmusp.relation.reference | Pruthi RK, 2010, THROMB RES, V126, P543, DOI 10.1016/j.thromres.2010.09.015 | eng |
hcfmusp.relation.reference | Pukac LA, 1997, BIOTECHNIQUES, V23, P385, DOI 10.2144/97233bm08 | eng |
hcfmusp.relation.reference | RUGGERI ZM, 1981, BLOOD, V57, P1140 | eng |
hcfmusp.relation.reference | RUGGERI ZM, 1980, J CLIN INVEST, V65, P1318, DOI 10.1172/JCI109795 | eng |
hcfmusp.relation.reference | Sadler JE, 2006, J THROMB HAEMOST, V4, P2103, DOI 10.1111/j.1538-7836.2006.02146.x | eng |
hcfmusp.relation.reference | Sadler J. E., 2013, HEMOSTASIS THROMBOSI, P670 | eng |
hcfmusp.relation.reference | SANDERS WE, 1988, LAB INVEST, V59, P443 | eng |
hcfmusp.relation.reference | Sanders YV, 2015, BLOOD, V125, P3006, DOI 10.1182/blood-2014-09-603241 | eng |
hcfmusp.relation.reference | Santoro ML, 2004, THROMB HAEMOSTASIS, V92, P369, DOI 10.1160/TH04-02-0120 | eng |
hcfmusp.relation.reference | Schneppenheim R, 2001, BLOOD, V97, P2059, DOI 10.1182/blood.V97.7.2059 | eng |
hcfmusp.relation.reference | Seidel H., 2017, RES PRACT THROMB SS1, V1, P717 | eng |
hcfmusp.relation.reference | Serrano SMT, 2007, FEBS J, V274, P3611, DOI 10.1111/j.1742-4658.2007.05895.x | eng |
hcfmusp.relation.reference | Smejkal GB, 2003, ELECTROPHORESIS, V24, P582, DOI 10.1002/elps.200390068 | eng |
hcfmusp.relation.reference | Springer TA, 2014, BLOOD, V124, P1412, DOI 10.1182/blood-2014-05-378638 | eng |
hcfmusp.relation.reference | Studt JD, 2001, AM J CLIN PATHOL, V116, P567 | eng |
hcfmusp.relation.reference | TAKAHASHI H, 1984, BLOOD, V64, P1254 | eng |
hcfmusp.relation.reference | Vincentelli A, 2003, NEW ENGL J MED, V349, P343, DOI 10.1056/NEJMoa022831 | eng |
hcfmusp.relation.reference | von Willebrand EA, 1999, HAEMOPHILIA, V5, P223 | eng |
hcfmusp.relation.reference | Weiss DR, 2008, THROMB HAEMOSTASIS, V100, P949, DOI 10.1160/TH08-06-0403 | eng |
hcfmusp.relation.reference | World Federation of Hemophilia, 2016, REP ANN GLOB SURV 20, P64 | eng |
hcfmusp.relation.reference | Yamashita KM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002814 | eng |
hcfmusp.relation.reference | ZIMMERMAN TS, 1986, J CLIN INVEST, V77, P947, DOI 10.1172/JCI112394 | eng |
hcfmusp.scopus.lastupdate | 2024-05-10 | |
relation.isAuthorOfPublication | bbc1905d-5fd1-4e63-85f7-2005887820d8 | |
relation.isAuthorOfPublication | 37a68e33-d879-4897-9d69-330f781c6585 | |
relation.isAuthorOfPublication | 8f98eea9-93a5-464f-a43a-046d80146491 | |
relation.isAuthorOfPublication | 313da143-42e1-47de-8616-9b5be5b4606b | |
relation.isAuthorOfPublication | f5b18e21-f58b-4ced-8e7e-8a2c23745396 | |
relation.isAuthorOfPublication.latestForDiscovery | bbc1905d-5fd1-4e63-85f7-2005887820d8 |
Arquivos
Pacote Original
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- art_THOMAZINI_Optimization_of_von_Willebrand_factor_multimer_analysis_in_2019.PDF
- Tamanho:
- 2.26 MB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)